Ferritin iron minerals are chelator targets, antioxidants, and coated, dietary iron.
Cellular ferritin is central for iron balance during transfusions therapies; serum ferritin is a small fraction of body ferritin, albeit a convenient reporter. Iron overload induces extra ferritin protein synthesis but the protein is overfilled with the extra iron that damages ferritin, with conversion to toxic hemosiderin. Three new approaches that manipulate ferritin to address excess iron, hemosiderin, and associated oxidative damage in Cooley's Anemia and other iron overload conditions are faster removal of ferritin iron with chelators guided to ferritin gated pores by peptides; more ferritin protein synthesis using ferritin mRNA activators, by metal complexes that target mRNA 3D structures; and determining if endocytotic absorption of iron from legumes, which is mostly ferritin, is regulated during iron overload to prevent excess iron entry while providing protein. More of a focus on ferritin features, including protein cage structure, iron mineral, regulatable mRNA, and specific gut absorption properties, will achieve the three novel experimental goals for managing iron homeostasis with transfusion therapies.
Theil
Elizabeth C
EC
Children's Hospital Oakland Research Institute, Oakland, California, USA. etheil@chori.org
D000975:Antioxidants / Q000737:chemistry / Q000378:metabolism*; D004032:Diet; D005293:Ferritins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D006485:Hemosiderin / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000737:chemistry / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D019190:Iron Overload / Q000209:etiology / Q000378:metabolism; D019266:Iron, Dietary / Q000378:metabolism*; D008903:Minerals / Q000737:chemistry / Q000378:metabolism*; D008958:Models, Molecular; D010084:Oxidation-Reduction; D011487:Protein Conformation; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D017086:beta-Thalassemia / Q000150:complications / Q000628:therapy
D000975:Antioxidants; D007502:Iron Chelating Agents; D019266:Iron, Dietary; D008903:Minerals; D012333:RNA, Messenger; D005293:Ferritins; D006485:Hemosiderin; D007501:Iron